Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study

Conclusions: Data from this longitudinal study of EPT quitters suggest that genetic variation in two hormone metabolism pathway genes, SLCO1B1 and ARSC, may be associated with change in MD after women stop using EPT. Larger longitudinal studies are needed to confirm our findings.

http://breast-cancer-research.com/content/16/6/477

Source: Breast Cancer Research - December 11, 2014 Category: Cancer & Oncology Authors: Eunjung LeeJianning LuoYu-Chen SuJuan LewingerFredrick SchumacherDavid Van Den BergAnna WuLeslie BernsteinGiske Ursin Source Type: research